|
US6194006B1
(en)
*
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
|
US7919119B2
(en)
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
|
WO2001056635A1
(de)
*
|
2000-02-01 |
2001-08-09 |
Disetronic Licensing Ag |
Behälter und vorrichtung zur verabreichung einer substanz
|
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
|
US6495164B1
(en)
*
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
|
CN1551770A
(zh)
|
2001-07-06 |
2004-12-01 |
������ҩ������˾ |
羟吗啡酮控释制剂
|
|
PL208484B1
(pl)
|
2001-07-06 |
2011-05-31 |
Penwest Pharmaceuticals Company |
Sposoby wytwarzania preparatów oksymorfonu o przedłużonym uwalnianiu
|
|
US7094369B2
(en)
|
2002-03-29 |
2006-08-22 |
Scimed Life Systems, Inc. |
Processes for manufacturing polymeric microspheres
|
|
US7462366B2
(en)
|
2002-03-29 |
2008-12-09 |
Boston Scientific Scimed, Inc. |
Drug delivery particle
|
|
US7131997B2
(en)
|
2002-03-29 |
2006-11-07 |
Scimed Life Systems, Inc. |
Tissue treatment
|
|
US7053134B2
(en)
|
2002-04-04 |
2006-05-30 |
Scimed Life Systems, Inc. |
Forming a chemically cross-linked particle of a desired shape and diameter
|
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
|
US7157102B1
(en)
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
|
US6972291B2
(en)
*
|
2002-07-02 |
2005-12-06 |
Bernstein Richard K |
Method for reducing food intake
|
|
US7449236B2
(en)
|
2002-08-09 |
2008-11-11 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
|
US7842377B2
(en)
*
|
2003-08-08 |
2010-11-30 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
|
US20040109886A1
(en)
*
|
2002-08-27 |
2004-06-10 |
Larry Rigby |
Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent
|
|
US8012454B2
(en)
|
2002-08-30 |
2011-09-06 |
Boston Scientific Scimed, Inc. |
Embolization
|
|
US7883490B2
(en)
|
2002-10-23 |
2011-02-08 |
Boston Scientific Scimed, Inc. |
Mixing and delivery of therapeutic compositions
|
|
US7588825B2
(en)
|
2002-10-23 |
2009-09-15 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
|
US7637900B2
(en)
*
|
2003-03-13 |
2009-12-29 |
Cheryl Burgess |
Methods of administering a material into a patient for dermal enhancement
|
|
US7279579B2
(en)
*
|
2003-06-04 |
2007-10-09 |
Alkermes, Inc. |
Polymorphic forms of naltrexone
|
|
US20050031713A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Elliot Ehrich |
Methods for administering active agents to CYP3A4 sensitive patients
|
|
US6987111B2
(en)
|
2003-08-06 |
2006-01-17 |
Alkermes Controlled Therapeutics, Ii |
Aripiprazole, olanzapine and haloperidol pamoate salts
|
|
US7976823B2
(en)
|
2003-08-29 |
2011-07-12 |
Boston Scientific Scimed, Inc. |
Ferromagnetic particles and methods
|
|
CN1856296A
(zh)
*
|
2003-09-30 |
2006-11-01 |
阿库斯菲尔公司 |
可注射的、口服、或局部用缓释药物制剂
|
|
US7901770B2
(en)
|
2003-11-04 |
2011-03-08 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
|
BRPI0507210A
(pt)
*
|
2004-02-23 |
2007-06-12 |
Euro Celtique Sa |
dispositivo que impede o uso indevido para administração transdérmica de opióide
|
|
US7736671B2
(en)
|
2004-03-02 |
2010-06-15 |
Boston Scientific Scimed, Inc. |
Embolization
|
|
US20050245461A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
|
US8173176B2
(en)
|
2004-03-30 |
2012-05-08 |
Boston Scientific Scimed, Inc. |
Embolization
|
|
US7919499B2
(en)
*
|
2004-04-22 |
2011-04-05 |
Alkermes, Inc. |
Naltrexone long acting formulations and methods of use
|
|
US7311861B2
(en)
|
2004-06-01 |
2007-12-25 |
Boston Scientific Scimed, Inc. |
Embolization
|
|
US7858183B2
(en)
|
2005-03-02 |
2010-12-28 |
Boston Scientific Scimed, Inc. |
Particles
|
|
US7727555B2
(en)
|
2005-03-02 |
2010-06-01 |
Boston Scientific Scimed, Inc. |
Particles
|
|
US7963287B2
(en)
|
2005-04-28 |
2011-06-21 |
Boston Scientific Scimed, Inc. |
Tissue-treatment methods
|
|
CN1872063B
(zh)
*
|
2005-06-03 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
纳美芬或其盐的长效注射用微球或组合物及其制备方法
|
|
US9463426B2
(en)
|
2005-06-24 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Methods and systems for coating particles
|
|
US7501179B2
(en)
|
2005-12-21 |
2009-03-10 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
|
US7947368B2
(en)
|
2005-12-21 |
2011-05-24 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
|
EP1810714A1
(de)
*
|
2006-01-19 |
2007-07-25 |
Holger Lars Hermann |
Verwendung einer Kombination von Heroin und Naloxon zur Drogensubstitution
|
|
RU2310449C1
(ru)
*
|
2006-05-17 |
2007-11-20 |
Руслан Геннадьевич Нервалев |
Способ лечения опиоидной и/или алкогольной зависимости
|
|
US8748448B2
(en)
|
2007-10-18 |
2014-06-10 |
Aiko Biotechnology |
Combination analgesic employing opioid agonist and neutral antagonist
|
|
JP2011500686A
(ja)
*
|
2007-10-18 |
2011-01-06 |
アイコ バイオテクノロジー |
オピオイドと中性アンタゴニストを用いる組合せ鎮痛剤
|
|
US8486448B2
(en)
|
2007-12-17 |
2013-07-16 |
Paladin Labs Inc. |
Misuse preventative, controlled release formulation
|
|
ES2509497T3
(es)
|
2008-12-16 |
2014-10-17 |
Paladin Labs Inc. |
Formulación de liberación controlada para evitar un uso indebido
|
|
US20100196436A1
(en)
*
|
2009-01-30 |
2010-08-05 |
Gooberman Lance L |
Implants containing disulfiram and an anti-inflammatory agent
|
|
US8791093B2
(en)
*
|
2009-05-29 |
2014-07-29 |
Lance L. Gooberman |
Pharmaceutical delivery systems for treatment of substance abuse and other addictions
|
|
MX339408B
(es)
*
|
2010-03-09 |
2016-05-24 |
Alkermes Pharma Ireland Ltd |
Composiciones farmaceuticas entericas resistentes al alcohol.
|
|
RU2476209C1
(ru)
*
|
2012-02-29 |
2013-02-27 |
Станислав Анатольевич Кедик |
Имплантируемое лекарственное средство на основе налтрексона для лечения пациентов, зависимых от алкоголя или опиатов
|
|
EP3031449A4
(en)
|
2013-08-06 |
2017-05-10 |
Dong Kook Pharm. Co., Ltd |
Entecavir microspheres and pharmaceutical composition for parenteral administration containing same
|
|
WO2016013993A1
(en)
*
|
2014-07-25 |
2016-01-28 |
Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. |
Stable preservative free ophthalmic formulations of opioid antagonists
|
|
KR102639578B1
(ko)
|
2018-10-15 |
2024-02-21 |
주식회사 종근당 |
주사 가능한 장기-지속형 날트렉손 마이크로입자 조성물
|
|
GR1009871B
(el)
*
|
2019-07-30 |
2020-11-12 |
Φαρματεν Α.Β.Ε.Ε. |
Φαρμακευτικο σκευασμα που περιλαμβανει μικροσφαιριδια ναλτρεξονης και μεθοδος παρασκευης αυτου
|
|
US20210059943A1
(en)
*
|
2019-09-04 |
2021-03-04 |
Buffalo Pacific LLC |
Systems and methods addressing multiple aspects to provide a comprehensive recovery program for addictions, chronic conditions and diseases
|
|
AU2022232414B2
(en)
*
|
2021-03-09 |
2025-06-05 |
Inventage Lab Inc. |
Sustained formulation for prevention or treatment of autoimmune disease containing naltrexone and method using same
|
|
JP2024541381A
(ja)
*
|
2021-11-18 |
2024-11-08 |
インベンテージ ラボ インコーポレイテッド |
ナルトレキソンを含む徐放性注射用組成物およびその製造方法
|